Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.
Identifieur interne : 000021 ( France/Analysis ); précédent : 000020; suivant : 000022Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.
Auteurs : Jacques Fantini [France] ; Coralie Di Scala [France] ; Henri Chahinian [France] ; Nouara Yahi [France]Source :
- International journal of antimicrobial agents [ 1872-7913 ] ; 2020.
Abstract
The recent emergence of the novel pathogenic SARS-coronavirus 2 (SARS-CoV-2) is responsible for a worldwide pandemic. Given the global health emergency, drug repositioning is the most reliable option to design an efficient therapy for infected patients without delay. The first step of the viral replication cycle [i.e. attachment to the surface of respiratory cells, mediated by the spike (S) viral protein] offers several potential therapeutic targets. The S protein uses the angiotension-converting enzyme-2 (ACE-2) receptor for entry, but also sialic acids linked to host cell surface gangliosides. Using a combination of structural and molecular modelling approaches, this study showed that chloroquine (CLQ), one of the drugs currently under investigation for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity. A new type of ganglioside-binding domain at the tip of the N-terminal domain of the SARS-CoV-2 S protein was identified. This domain (111-158), which is fully conserved among clinical isolates worldwide, may improve attachment of the virus to lipid rafts and facilitate contact with the ACE-2 receptor. This study showed that, in the presence of CLQ [or its more active derivative, hydroxychloroquine (CLQ-OH)], the viral S protein is no longer able to bind gangliosides. The identification of this new mechanism of action of CLQ and CLQ-OH supports the use of these repositioned drugs to cure patients infected with SARS-CoV-2. The in-silico approaches used in this study might also be used to assess the efficiency of a broad range of repositioned and/or innovative drug candidates before clinical evaluation.
DOI: 10.1016/j.ijantimicag.2020.105960
PubMed: 32251731
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000335
- to stream PubMed, to step Curation: 000335
- to stream PubMed, to step Checkpoint: 000170
- to stream Ncbi, to step Merge: 003764
- to stream Ncbi, to step Curation: 003764
- to stream Ncbi, to step Checkpoint: 003764
- to stream Main, to step Merge: 000205
- to stream Main, to step Curation: 000205
- to stream Main, to step Exploration: 000205
- to stream France, to step Extraction: 000021
Links to Exploration step
pubmed:32251731Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.</title><author><name sortKey="Fantini, Jacques" sort="Fantini, Jacques" uniqKey="Fantini J" first="Jacques" last="Fantini">Jacques Fantini</name><affiliation wicri:level="4"><nlm:affiliation>INSERM UMR_S 1072, Marseille, France; Department of Biology, Aix-Marseille Université, Marseille, France. Electronic address: jacques.fantini@univ-amu.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM UMR_S 1072, Marseille, France; Department of Biology, Aix-Marseille Université, Marseille</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName><orgName type="university">Université d'Aix-Marseille</orgName></affiliation></author><author><name sortKey="Di Scala, Coralie" sort="Di Scala, Coralie" uniqKey="Di Scala C" first="Coralie" last="Di Scala">Coralie Di Scala</name><affiliation wicri:level="3"><nlm:affiliation>INMED, INSERM U1249, Parc Scientifique de Luminy, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INMED, INSERM U1249, Parc Scientifique de Luminy, Marseille</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName></affiliation></author><author><name sortKey="Chahinian, Henri" sort="Chahinian, Henri" uniqKey="Chahinian H" first="Henri" last="Chahinian">Henri Chahinian</name><affiliation wicri:level="4"><nlm:affiliation>INSERM UMR_S 1072, Marseille, France; Department of Biology, Aix-Marseille Université, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM UMR_S 1072, Marseille, France; Department of Biology, Aix-Marseille Université, Marseille</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName><orgName type="university">Université d'Aix-Marseille</orgName></affiliation></author><author><name sortKey="Yahi, Nouara" sort="Yahi, Nouara" uniqKey="Yahi N" first="Nouara" last="Yahi">Nouara Yahi</name><affiliation wicri:level="4"><nlm:affiliation>INSERM UMR_S 1072, Marseille, France; Department of Biology, Aix-Marseille Université, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM UMR_S 1072, Marseille, France; Department of Biology, Aix-Marseille Université, Marseille</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName><orgName type="university">Université d'Aix-Marseille</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32251731</idno><idno type="pmid">32251731</idno><idno type="doi">10.1016/j.ijantimicag.2020.105960</idno><idno type="wicri:Area/PubMed/Corpus">000335</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000335</idno><idno type="wicri:Area/PubMed/Curation">000335</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000335</idno><idno type="wicri:Area/PubMed/Checkpoint">000170</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000170</idno><idno type="wicri:Area/Ncbi/Merge">003764</idno><idno type="wicri:Area/Ncbi/Curation">003764</idno><idno type="wicri:Area/Ncbi/Checkpoint">003764</idno><idno type="wicri:Area/Main/Merge">000205</idno><idno type="wicri:Area/Main/Curation">000205</idno><idno type="wicri:Area/Main/Exploration">000205</idno><idno type="wicri:Area/France/Extraction">000021</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.</title><author><name sortKey="Fantini, Jacques" sort="Fantini, Jacques" uniqKey="Fantini J" first="Jacques" last="Fantini">Jacques Fantini</name><affiliation wicri:level="4"><nlm:affiliation>INSERM UMR_S 1072, Marseille, France; Department of Biology, Aix-Marseille Université, Marseille, France. Electronic address: jacques.fantini@univ-amu.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM UMR_S 1072, Marseille, France; Department of Biology, Aix-Marseille Université, Marseille</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName><orgName type="university">Université d'Aix-Marseille</orgName></affiliation></author><author><name sortKey="Di Scala, Coralie" sort="Di Scala, Coralie" uniqKey="Di Scala C" first="Coralie" last="Di Scala">Coralie Di Scala</name><affiliation wicri:level="3"><nlm:affiliation>INMED, INSERM U1249, Parc Scientifique de Luminy, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INMED, INSERM U1249, Parc Scientifique de Luminy, Marseille</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName></affiliation></author><author><name sortKey="Chahinian, Henri" sort="Chahinian, Henri" uniqKey="Chahinian H" first="Henri" last="Chahinian">Henri Chahinian</name><affiliation wicri:level="4"><nlm:affiliation>INSERM UMR_S 1072, Marseille, France; Department of Biology, Aix-Marseille Université, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM UMR_S 1072, Marseille, France; Department of Biology, Aix-Marseille Université, Marseille</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName><orgName type="university">Université d'Aix-Marseille</orgName></affiliation></author><author><name sortKey="Yahi, Nouara" sort="Yahi, Nouara" uniqKey="Yahi N" first="Nouara" last="Yahi">Nouara Yahi</name><affiliation wicri:level="4"><nlm:affiliation>INSERM UMR_S 1072, Marseille, France; Department of Biology, Aix-Marseille Université, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM UMR_S 1072, Marseille, France; Department of Biology, Aix-Marseille Université, Marseille</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName><orgName type="university">Université d'Aix-Marseille</orgName></affiliation></author></analytic><series><title level="j">International journal of antimicrobial agents</title><idno type="eISSN">1872-7913</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The recent emergence of the novel pathogenic SARS-coronavirus 2 (SARS-CoV-2) is responsible for a worldwide pandemic. Given the global health emergency, drug repositioning is the most reliable option to design an efficient therapy for infected patients without delay. The first step of the viral replication cycle [i.e. attachment to the surface of respiratory cells, mediated by the spike (S) viral protein] offers several potential therapeutic targets. The S protein uses the angiotension-converting enzyme-2 (ACE-2) receptor for entry, but also sialic acids linked to host cell surface gangliosides. Using a combination of structural and molecular modelling approaches, this study showed that chloroquine (CLQ), one of the drugs currently under investigation for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity. A new type of ganglioside-binding domain at the tip of the N-terminal domain of the SARS-CoV-2 S protein was identified. This domain (111-158), which is fully conserved among clinical isolates worldwide, may improve attachment of the virus to lipid rafts and facilitate contact with the ACE-2 receptor. This study showed that, in the presence of CLQ [or its more active derivative, hydroxychloroquine (CLQ-OH)], the viral S protein is no longer able to bind gangliosides. The identification of this new mechanism of action of CLQ and CLQ-OH supports the use of these repositioned drugs to cure patients infected with SARS-CoV-2. The in-silico approaches used in this study might also be used to assess the efficiency of a broad range of repositioned and/or innovative drug candidates before clinical evaluation.</div></front></TEI><affiliations><list><country><li>France</li></country><region><li>Provence-Alpes-Côte d'Azur</li></region><settlement><li>Marseille</li></settlement><orgName><li>Université d'Aix-Marseille</li></orgName></list><tree><country name="France"><region name="Provence-Alpes-Côte d'Azur"><name sortKey="Fantini, Jacques" sort="Fantini, Jacques" uniqKey="Fantini J" first="Jacques" last="Fantini">Jacques Fantini</name></region><name sortKey="Chahinian, Henri" sort="Chahinian, Henri" uniqKey="Chahinian H" first="Henri" last="Chahinian">Henri Chahinian</name><name sortKey="Di Scala, Coralie" sort="Di Scala, Coralie" uniqKey="Di Scala C" first="Coralie" last="Di Scala">Coralie Di Scala</name><name sortKey="Yahi, Nouara" sort="Yahi, Nouara" uniqKey="Yahi N" first="Nouara" last="Yahi">Nouara Yahi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000021 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000021 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= France
|étape= Analysis
|type= RBID
|clé= pubmed:32251731
|texte= Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/RBID.i -Sk "pubmed:32251731" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |